Not that long ago, infertility was something people endured in silence and women almost always carried the blame. Medical options were extremely limited, and even adoption came with heavy social stigma.

Then everything changed in 1978, with the birth of the world’s first IVF baby in Oldham. Science opened a new door, offering people a real chance at biological parenthood beyond natural limits.

By the early 2000s, assisted reproductive technologies had spread globally but not evenly. Some countries embraced them, while others imposed strict bans based on ethical, religious, or legal concerns.

That gap sparked a new kind of movement. Intended parents began crossing borders, first regionally, then globally searching not just for treatment, but for possibility.

They weren’t just traveling.
They were chasing a real chance to build a family.

It has evolved into a multi billion dollar global industry, shaped by deep legal, economic, and biological inequalities between countries.

The numbers are striking. According to Grand View Research, the global fertility market surpassed $33 billion in 2023 and is projected to exceed $50 billion by 2030.

The Spanish Fertility Society reports that over 40% of IVF patients come from abroad, largely due to flexible egg donation laws.

Ukraine also emerged as a major surrogacy hub, driven by lower costs and permissive regulations. Programs there typically ranged between $30,000 and $50,000 USD, compared to $100,000+ in the United States.

This demand has created entire ecosystems: agencies, legal advisors, translators, donor databases, and cross-border coordinators.

Clinics in places like Tijuana and Cancún actively market to U.S. patients, offering IVF cycles at roughly half the cost.

This industry doesn’t just move people, it moves eggs, sperm, embryos, and even pregnancies across borders.